112 related articles for article (PubMed ID: 38945936)
1. Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer's Disease: Recent Advances and Perspectives.
Suzuki N; Hatta T; Ito M; Kusakabe KI
Chem Pharm Bull (Tokyo); 2024; 72(7):602-609. PubMed ID: 38945936
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: Recent treatment strategies.
Vaz M; Silvestre S
Eur J Pharmacol; 2020 Nov; 887():173554. PubMed ID: 32941929
[TBL] [Abstract][Full Text] [Related]
5. Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.
Boutajangout A; Wisniewski T
Gerontology; 2014; 60(5):381-5. PubMed ID: 24732638
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein.
Parums DV
Med Sci Monit; 2021 Jul; 27():e934077. PubMed ID: 34305135
[TBL] [Abstract][Full Text] [Related]
7. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
8. Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Silvestro S; Valeri A; Mazzon E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216126
[TBL] [Abstract][Full Text] [Related]
9. Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials.
Tian Hui Kwan A; Arfaie S; Therriault J; Rosa-Neto P; Gauthier S
Dement Geriatr Cogn Disord; 2020; 49(4):334-348. PubMed ID: 33321511
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic approaches for Alzheimer's disease.
Wisniewski T; Goñi F
Neuron; 2015 Mar; 85(6):1162-76. PubMed ID: 25789753
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer disease therapy--moving from amyloid-β to tau.
Giacobini E; Gold G
Nat Rev Neurol; 2013 Dec; 9(12):677-86. PubMed ID: 24217510
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.
Song C; Shi J; Zhang P; Zhang Y; Xu J; Zhao L; Zhang R; Wang H; Chen H
Transl Neurodegener; 2022 Mar; 11(1):18. PubMed ID: 35300725
[TBL] [Abstract][Full Text] [Related]
13. Status and future directions of clinical trials in Alzheimer's disease.
Plascencia-Villa G; Perry G
Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008
[TBL] [Abstract][Full Text] [Related]
14. Passive Immunotherapies Targeting Amyloid-
Marković M; Milošević J; Wang W; Cao Y
Mol Pharmacol; 2023 Dec; 105(1):1-13. PubMed ID: 37907353
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
[TBL] [Abstract][Full Text] [Related]
16. Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein.
Panza F; Solfrizzi V; Frisardi V; Imbimbo BP; Capurso C; D'Introno A; Colacicco AM; Seripa D; Vendemiale G; Capurso A; Pilotto A
Aging Clin Exp Res; 2009 Dec; 21(6):386-406. PubMed ID: 20154508
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.
Blennow K; Hampel H; Zetterberg H
Neuropsychopharmacology; 2014 Jan; 39(1):189-201. PubMed ID: 23799530
[TBL] [Abstract][Full Text] [Related]
18. Passive immunotherapy for Alzheimer's disease: challenges & future directions.
Yi LX; Tan EK; Zhou ZD
J Transl Med; 2024 May; 22(1):430. PubMed ID: 38715084
[TBL] [Abstract][Full Text] [Related]
19. Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease.
Ji W; Gong B; Jin H; Chen X; Li P; Cheng W; Zhao Y; He B; Zhuang J; Gao J; Yin Y
Mini Rev Med Chem; 2021; 21(19):3062-3072. PubMed ID: 34353254
[TBL] [Abstract][Full Text] [Related]
20. Drugs for Targeted Therapies of Alzheimer's Disease.
Tam C; Wong JH; Ng TB; Tsui SKW; Zuo T
Curr Med Chem; 2019; 26(2):335-359. PubMed ID: 29714133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
